Alexandra Twin has 15+ years of experience as an editor and writer, covering financial news for public and private companies. Vikki Velasquez is a researcher and writer who has managed, coordinated, ...
Epidural steroid shots for back pain had mixed results, an AAN review showed. The treatment demonstrated promising short-term benefits for radiculopathy patients. In other situations, benefits were ...
Research finds that friendship is less of an exchange of giving and receiving, and more of a support system for unpredictable times. Decades of research suggest that the quality of our social ties ...
ADDITIONAL STUDIES. WELL, IN TONIGHT’S WOMAN’S DOCTOR, IF YOU’RE FEELING STIFFNESS IN YOUR NECK THAT RADIATES DOWN YOUR ARM, NUMBNESS OR TINGLING OR WEAKNESS IN YOUR HANDS, THERE ARE TWO CONDITIONS ...
Lumbar radiculopathy, or sciatic neuritis, is a condition that usually results from a pinched nerve or a herniated disc, though other causes are possible. Typical symptoms are weakness, pain, numbness ...
This video will describe how cervical radiculopathy can cause pain, numbness and tingling down a persons arm, hands or fingers. Treatment options for this condition are also discussed. Woman blames ...
Cervical radiculopathy is a condition caused by a pinched nerve in your neck. It happens when your cervical spinal cord or nerve roots arising from it become compressed by the cervical vertebrae. Your ...
Scientists have developed a new systematic review to summarize for neurologists and other clinicians the evidence for epidural steroid injections and whether they reduce pain and disability for people ...
A former Senior Publishing Editor on the Dow Jones Newswires team at The Wall Street Journal, Aaron earned a Bachelor's degree in Economics from the University of Michigan and a Master's in Journalism ...
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced results from its Phase 2 study of suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal ...
Vertex Pharmaceuticals (VRTX) announced results from its Phase 2 study of suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal inhibitor in people with painful lumbosacral ...
– Treatment with the highly selective NaV1.8 pain signal inhibitor suzetrigine met the primary endpoint with a statistically significant and clinically meaningful 2.02 point within-group reduction ...